<code id='8600D45A7F'></code><style id='8600D45A7F'></style>
    • <acronym id='8600D45A7F'></acronym>
      <center id='8600D45A7F'><center id='8600D45A7F'><tfoot id='8600D45A7F'></tfoot></center><abbr id='8600D45A7F'><dir id='8600D45A7F'><tfoot id='8600D45A7F'></tfoot><noframes id='8600D45A7F'>

    • <optgroup id='8600D45A7F'><strike id='8600D45A7F'><sup id='8600D45A7F'></sup></strike><code id='8600D45A7F'></code></optgroup>
        1. <b id='8600D45A7F'><label id='8600D45A7F'><select id='8600D45A7F'><dt id='8600D45A7F'><span id='8600D45A7F'></span></dt></select></label></b><u id='8600D45A7F'></u>
          <i id='8600D45A7F'><strike id='8600D45A7F'><tt id='8600D45A7F'><pre id='8600D45A7F'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:explore    Page View:33327
          the U.S. Medicare Handbook is photographed in Washington.
          Pablo Martinez Monsivais/AP

          Roughly 33.4 million adults older than 65 and people with disabilities were enrolled in a Medicare Advantage plan as the calendar flipped to 2024 — another year of steady, albeit slower, growth for the taxpayer-funded program.

          Enrollment increased 7.1% year over year, which would make this year’s annual growth rate identical to last year’s, according to new federal Medicare Advantage enrollment data analyzed by STAT.

          advertisement

          The data reinforce how America’s Medicare program continues to shift toward a more privatized version that has not saved any money for taxpayers, has been linked to inappropriate coding practices, and has restricted care for older and vulnerable patients. And even though the federal government made several changes to Medicare Advantage for 2024 — changes that were vehemently opposed by the health insurance industry — the program’s growth has not been stunted, nor did insurers dramatically slash their offerings.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry
          Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

          GwenPetersen,38,anALSpatient,believesthattherecentfailureofAmylyx'sdrugRelyvriocouldstillteachresear

          read more
          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more

          My daughter's legacy lives on through her writing, phage therapy

          MallorySmithatherdeskwritingthebook"TheGottliebNativeGarden:ACaliforniaLoveStory"JacobJonas“Wholives